Clostridium tetani bacteraemiaHALLIT, Rabih Riad; AFRIDI, Muhammad; SISON, Raymund et al.Journal of medical microbiology. 2013, Vol 62, Num 1, pp 155-156, issn 0022-2615, 2 p.Article

Women have a greater immunological response to effective virological HIV-1 therapyFINKEL, Diana G; JOHN, Genevieve; HOLLAND, Bart et al.AIDS (London). 2003, Vol 17, Num 13, pp 2009-2011, issn 0269-9370, 3 p.Article

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patientsAMOROSA, Valerianna K; SLIM, Jihad; MOUNZER, Karam et al.Antiviral therapy (London). 2010, Vol 15, Num 1, pp 91-99, issn 1359-6535, 9 p.Article

Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfectionHENRY, David H; SLIM, Jihad; LAMARCA, Anthony et al.AIDS research and human retroviruses. 2007, Vol 23, Num 1, pp 1-9, issn 0889-2229, 9 p.Article

Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: Final results of two randomized phase III trialsCASEIRO, Marcos M; NELSON, Mark; GREAVES, Wayne et al.The Journal of infection. 2012, Vol 65, Num 4, pp 326-335, issn 0163-4453, 10 p.Article

The Role of Postexercise Measurements in the Diagnosis of Peripheral Arterial Disease in HIV-Infected PatientsQAQA, Ashraf Y; DEBARI, Vincent A; ISBITAN, A et al.Angiology. 2011, Vol 62, Num 1, pp 10-14, issn 0003-3197, 5 p.Article

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialSULKOWSKI, Mark; POL, Stanislas; WENNING, Larissa et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 597-605, issn 1473-3099, 9 p.Article

Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patientsVACHON, Marie-Louise C; FACTOR, Stephanie H; SULKOWSKI, Mark S et al.Journal of hepatology. 2011, Vol 54, Num 1, pp 41-47, issn 0168-8278, 7 p.Article

Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection Is Safe and TolerableFÄTKENHEUER, Gerd; HOFFMANN, Christian; SCHÜRMANN, Dirk et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 1, pp 78-85, issn 1525-4135, 8 p.Article

Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment-Experienced Subjects: 48-Week Results of the VICTOR-E1 Phase 2 TrialSULEIMAN, Jamal; ZINGMAN, Barry S; WALMSLEY, Sharon et al.The Journal of infectious diseases. 2010, Vol 201, Num 4, pp 590-599, issn 0022-1899, 10 p.Article

Gemini : A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in AdultsWALMSLEY, Sharon; AVIHINGSANON, Anchalee; SCHUTZ, Malte et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 4, pp 367-374, issn 1525-4135, 8 p.Article

Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients : the ASCENT (CCR102881) studyCURRIER, Judith; LAZZARIN, Adriano; SLOAN, Louis et al.Antiviral therapy (London). 2008, Vol 13, Num 2, pp 297-306, issn 1359-6535, 10 p.Article